This move is archived. Current quotes and coverage live on the stock page.
Get TELO alerts:
Telo Genomics Corp faces a significant downturn as its stock drops 11.11% in a single trading session.
In a challenging trading day, Telo Genomics Corp (TELO.V) saw its stock price fall by 11.11%, closing at CA$0.04. This drop raises concerns among investors about the company's future prospects, especially given the lack of recent news to explain the downturn.
Advertisement
Telo Genomics Corp
TELO.V
TELO.V
Telo Genomics Corp
WealthAwesomeMarket cap
$5.02M
52W high
$0.10
52W low
$0.04
1W change
+11.11%
Beta
0.18
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on TELO's historical volatility
30-Day Vol
134.9%
Annualized
90-Day Vol
124.9%
Annualized
Trend (90d)
+0.0%
Annualized drift
90d Mean
C$0.05
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.05 | C$0.03 – C$0.08 |
| 60 trading days | C$0.05 | C$0.03 – C$0.10 |
| 90 trading days | C$0.05 | C$0.02 – C$0.11 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Investors should remain vigilant and consider the implications of this sudden decline, particularly in the context of Telo Genomics' overall market position and recent operational changes.
Telo Genomics Corp stock down 11.11% today
The market cap of Telo Genomics now stands at CA$4,519,372, reflecting investor concerns over its viability.
Bull case
Despite today's decline, Telo Genomics is expanding its operations by moving to a larger facility in Toronto. This could set the company up for future growth.
Bear case
The sharp drop in stock price suggests investor skepticism, especially since there’s been no positive news or catalysts to boost confidence in the company's performance.
Market Reaction
Advertisement
The 11.11% drop in Telo Genomics' stock price today has raised eyebrows among investors. With a closing price of CA$0.04, the company’s market cap now sits at approximately CA$4.5 million. This decline comes without any significant news or announcements that could have prompted such a reaction, leaving many to speculate about investor sentiment.
Operational Changes
Telo Genomics recently announced the relocation of its clinical laboratories to a new facility in Toronto, which could signal growth potential. However, the lack of immediate positive news following this operational change might have contributed to today's stock decline. Investors are advised to monitor how these changes will influence the company's performance moving forward. For more details on Telo Genomics' operational updates, visit their stock page.
Looking Ahead
As Telo Genomics navigates this downturn, investors should consider the broader implications of today’s trading activity. The absence of news combined with the significant drop may indicate underlying issues that need to be addressed. For ongoing updates and insights, keep an eye on Telo Genomics' developments through their stock page.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
